![Helmuth van Es](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Helmuth van Es
Founder at Antabio SAS
Helmuth van Es active positions
Companies | Position | Start | End |
---|---|---|---|
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Director/Board Member | 2009-10-07 | - |
Founder | 2009-10-07 | - | |
Audion Therapeutics BV
![]() Audion Therapeutics BV Pharmaceuticals: MajorHealth Technology Audion Therapeutics BV is a biopharmaceutical firm. It specializes in the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss. The company was founded by Rolf Jan Rutten, Albert Edge, and Helmuth van Es and is headquartered in Amsterdam, the Netherlands. | Chief Tech/Sci/R&D Officer | - | - |
Founder | - | - |
Career history of Helmuth van Es
Former positions of Helmuth van Es
Companies | Position | Start | End |
---|---|---|---|
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Chief Executive Officer | 2014-12-31 | 2023-02-28 |
Founder | 2014-12-31 | 2023-02-28 | |
Spinnovation Holding BV
![]() Spinnovation Holding BV Medical/Nursing ServicesHealth Services Spinnovation Holding BV operates as a holding company with interests in solving problems in material, chemical, and biological sciences via a unique combination of NMR spectroscopic methods. The firm provides access to a high-tech NMR platform based on spectrometers ranging from 300 MHz to 800 MHz. The company was founded in 2004 and is headquartered in Nijmegen, the Netherlands. | Corporate Officer/Principal | - | - |
GALAPAGOS NV | Founder | 1999-06-29 | - |
Statistics
International
Netherlands | 4 |
France | 2 |
Belgium | 2 |
Operational
Founder | 4 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 4 |
Health Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GALAPAGOS NV | Health Technology |
Private companies | 4 |
---|---|
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Health Technology |
Audion Therapeutics BV
![]() Audion Therapeutics BV Pharmaceuticals: MajorHealth Technology Audion Therapeutics BV is a biopharmaceutical firm. It specializes in the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss. The company was founded by Rolf Jan Rutten, Albert Edge, and Helmuth van Es and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Spinnovation Holding BV
![]() Spinnovation Holding BV Medical/Nursing ServicesHealth Services Spinnovation Holding BV operates as a holding company with interests in solving problems in material, chemical, and biological sciences via a unique combination of NMR spectroscopic methods. The firm provides access to a high-tech NMR platform based on spectrometers ranging from 300 MHz to 800 MHz. The company was founded in 2004 and is headquartered in Nijmegen, the Netherlands. | Health Services |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Commercial Services |
- Stock Market
- Insiders
- Helmuth van Es
- Experience